About Mink Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.minktherapeutics.com
Frequently Asked Questions
What is the 52-week range for INKT?
The 52-week high is $16.927 and the 52-week low is $8.48.
What is the P/E ratio for INKT?
The P/E ratio data is currently unavailable.
What is the dividend yield for INKT?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -168.87%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 6.29.
Analyst Recommendation Trends
Wall Street analyst consensus for INKT over the last few months:
Latest INKT News
MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026
agenT-797 enables tumor-cell killing in a human relevant model of checkpoint inhibitor–resistant colorectal cancer liver metastasesNative and engineered iNKT cells eliminate senescent tumor cells and fibroblasts in preclinical models, supporting complementary approaches to cancer treatment NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to res
MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy
Clinical-stage agenT-797 iNKT platform selected as therapeutic cell platform for ARPA-H BoSS program aimed at taking living medicines from cryogenic storage toward room temperature ARPA-H has committed up to $87 million across the four-year BoSS program to reduce cold-chain dependence and expand access to cell-based medicines NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invaria
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-01 | Holcomb John Bradley | +1,233 | $10.95 | $13,501 |
| 2026-09-01 | Behner Peter | +1,485 | $10.95 | $16,261 |
| 2026-09-01 | Ryan Barbara | +1,622 | $10.95 | $17,761 |
| 2026-09-01 | Corvese Brian | +1,633 | $10.95 | $17,881 |
| 2026-09-01 | WIINBERG ULF | +1,279 | $10.95 | $14,005 |
| 2026-06-04 | Ryan Barbara | -1,000 | $12.7995 | $12,800 |
| 2026-06-04 | Ryan Barbara | -500 | $12.6835 | $6,342 |
| 2026-06-01 | Holcomb John Bradley | +1,091 | $12.38 | $13,507 |
| 2026-06-01 | Behner Peter | +1,313 | $12.38 | $16,255 |
| 2026-06-01 | Ryan Barbara | +1,434 | $12.38 | $17,753 |
| 2026-06-01 | Corvese Brian | +1,444 | $12.38 | $17,877 |
| 2026-06-01 | WIINBERG ULF | +1,131 | $12.38 | $14,002 |
| 2026-03-10 | Ryan Barbara | -500 | $15.3 | $7,650 |
| 2026-03-10 | Ryan Barbara | -500 | $15.5652 | $7,783 |
| 2026-03-10 | Ryan Barbara | -300 | $15.2822 | $4,585 |
| 2026-03-09 | Ryan Barbara | -200 | $10.1725 | $2,035 |
| 2026-03-02 | Holcomb John Bradley | +1,239 | $10.9 | $13,505 |
| 2026-03-02 | Behner Peter | +1,491 | $10.9 | $16,252 |
| 2026-03-02 | Ryan Barbara | +1,629 | $10.9 | $17,756 |
| 2026-03-02 | Corvese Brian | +1,640 | $10.9 | $17,876 |
| 2026-03-02 | WIINBERG ULF | +1,285 | $10.9 | $14,007 |
| 2026-03-02 | Ryan Barbara | -100 | $10.8258 | $1,083 |
| 2026-02-27 | Ryan Barbara | -400 | $10.8583 | $4,343 |
| 2026-01-02 | Buell Jennifer | -10,024 | $11.12 | $111,467 |
| 2026-01-02 | Buell Jennifer | +50,000 | - | - |
| 2026-01-02 | Buell Jennifer | +31,474 | $11.12 | $349,991 |
| 2026-01-02 | Behner Peter | +5,395 | - | - |
| 2026-01-02 | Ryan Barbara | +5,395 | - | - |
| 2026-01-02 | Corvese Brian | +5,395 | - | - |
| 2026-01-02 | WIINBERG ULF | +5,395 | - | - |
| 2025-12-01 | Behner Peter | +1,466 | $11.09 | $16,258 |
| 2025-12-01 | Holcomb John Bradley | +1,128 | $11.09 | $12,510 |
| 2025-12-01 | Kadlec Robert Peter | +1,218 | $11.09 | $13,508 |
| 2025-12-01 | Ryan Barbara | +1,601 | $11.09 | $17,755 |
| 2025-12-01 | Corvese Brian | +1,612 | $11.09 | $17,877 |
| 2025-12-01 | WIINBERG ULF | +1,263 | $11.09 | $14,007 |